Antagonism of N-methyl-D-aspartate receptors by σ site ligands: Potency, subtype-selectivity and mechanisms of inhibition

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 326-338

  Whittemore, E R ^a   Ilyin, V I ^a   Woodward, R M ^a,b  

^a CoCensys Pharmaceuticals Inc ^*  (United States)

^b Hitachi Chemical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; TRIFLUPERIDOL;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; DRUG ANTAGONISM; DRUG POTENCY; GENE EXPRESSION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SCHIZOPHRENIA; STEADY STATE;

ANIMALS; CELLS, CULTURED; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; LIGANDS; NEUROPROTECTIVE AGENTS; OOCYTES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; XENOPUS;

EID: 0030867518     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. BANERJEE, S. P., ZUCK, L. G., YABLONSKY-ALTER, E. AND LIDSKY, T. I.: Glutamate agonist activity: implications for antipsychotic drug actions and schizophrenia. NeuroReport 6: 2500-2504, 1995.
2. BOOTH, R. G., WYRICK, S. D., BALDESSARINI, R. J., KULA, N. S., MYERS, A. M. AND MAILMAN, R. B.: A new sigma-like receptor recognized by phenylaminotetralins: ligand binding and functional studies. Mol. Pharmacol. 44: 1232-1239, 1993.
3. BOWEN, W. D., KIRSHNER, B. N., NEWMAN, A. H. AND RICE, K. C.: σ receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain. Eur. J. Pharmacol. 149: 399-400, 1988.
4. 3HK](+)-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol. Neuropharmacol. 3: 117-126, 1993.
5. CARTER, C., BENAVIDES, J., DANA, C., SCHOEMAKER, H., PERRAULT, G., SANGER, D. AND SCATTON, B.: Noncompetitive NMDA receptor antagonists acting on the polyamine site. In Excitatory Amino Acid Antagonists, Frontiers in Pharmacology and Therapeutics, ed. by B. S. Meldrum, pp. 130-163, Blackwell Scientific Publications, Oxford, U.K., 1991.
6. CHURCH, J. AND LODGE, D.: Cyclazocaine and pentazocine as N-methylaspartate antagonists on cat and rat spinal neurons in vivo. J. Pharmacol. Exp. Ther. 253: 636-645, 1990.
7. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions. Br. J. Pharmacol. 113: 499-507, 1994.
8. 3H]-ifenprodil binding in rat brain membranes. J. Pharmacol. Exp. Ther. 280: 584-592, 1997.
9. 3H]-(+)-3-PPP to σ binding sites in rat brain. Neurosci. Lett. 116: 190-193, 1990.
10. DEBONNEL, G.: Current hypotheses on sigma receptors and their physiological role: Possible implications in psychiatry. J. Psychiatry Neurosci. 18: 157-172, 1993.
11. de COSTA, B. R. AND HE, X-S.: Structure-activity relationships and evolution of sigma receptor ligands (1976-present). In The Sigma Receptors, Neuroscience Perspectives Series, ed. by Y. Itzhak, pp. 45-111, Academic Press, London, U.K., 1994.
12. FERRIS, R. M., TANG, F. L. M., CHANG, K-J. AND RUSSEL, A.: Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain. Life Sci. 38: 2329-2337, 1986.
13. FLETCHER, E. J. AND MACDONALD, J. F.: Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eu. J. Pharmacol. 235: 291-295, 1993.
14. FLETCHER, E. J., CHURCH, J., ABDEL-HAMID, K. AND MACDONALD, J. F.: Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-tolyl)guanidine in mouse and rat cultured hippocampal pyramidal neurones. Br. J. Pharmacol. 109: 1196-1205, 1993.
15. FLETCHER, E. J., CHURCH, J., ABDEL-HAMID, K. AND MACDONALD, J. F.: Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Br. J. Pharmacol. 116: 2791-2800, 1995.
16. GLENNON, R. A., YOUSIF, M. Y., ISMAIEL, A. M., EL-ASHMAWY, M. B., HERDON, J. L., FISCHER, J. B., SERVER, A. C. AND HOWIE, K. J. B.: Novel 1-phenylpiperazine and piperidine derivatives as high affinity σ ligands. J. Med. Chem. 34: 3360-3365, 1991.
17. 3H]-dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 271: 212-219, 1994.
18. GONZALES-AVEAR, G. M. AND WERLING, L. L.: Sigma receptor regulation of noradrenaline release from rat hippocampal slices. Brain. Res. 673: 61-69, 1995.
19. 1-binding site. Proc. Natl. Acad. Sci. U.S.A. 93: 8072-8077, 1996.
20. 3H]-ifenprodil binding to sigma receptors in rat brain. Eur. J. Pharmacol. 236: 159-163, 1993.
21. HASHIMOTO, K. AND LONDON, E. D.: Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with sigma receptors. Eur. J. Pharmacol. 273: 307-310, 1995.
22. A receptor. Mol. Pharmacol. 49: 897-906, 1996.
23. 2+ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J. Pharmacol. Exp. Ther. 275: 207-214, 1995.
24. HE, X-S., BOWEN, W. D., LEE, K. S., WILLIAMS, W., WEINBERGER, D. R. AND DE COSTA, B. R.: Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites. J. Med. Chem. 36: 566-572, 1993.
25. HELLEWELL, S. B. AND BOWEN, W. D.: A sigmo-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 527: 244-253, 1990.
26. HELLEWELL, S. B., BRUCE, A., FEINSTEIN, G., ORRINGER, J., WILLIAMS, W. AND BOWEN, W. D.: Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: characterization by ligand binding and photoaffinity labelling. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 268: 9-18, 1994.
27. HUETTNER, J. E. AND BEAN, B. P.: Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. Natl. Acad. Sci. U.S.A. 85: 1307-1311, 1988.
28. ILYIN, V., WHITTEMORE, E. R. AND WOODWARD, R. M.: Antagonism of NMDA receptors by sigma site ligands. Soc. Neurosci. Abstr. 21: 835, 1995.
29. ILYIN, V. I., WHITTEMORE, E. R., GUASTELLA, J., WEBER, E. AND WOODWARD, R. M.: Subtype-specific inhibition of NMDA receptors by haloperidol. Mol. Pharmacol. 50: 1541-1550, 1996.
30. 125I]-N-(N-benzylpiperdin-4-yl)-4-iodobenzamide, a new σ receptor radiopharmaceutical: high affinity binding to MCF-7 breast tumor cells. J. Med. Chem. 37: 1737-1739, 1994.
31. 3H](+)-3-PPP σ binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 176: 247-248, 1990.
32. KEW, J. N. C., TRUBE, G. AND KEMP, J. A.: A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurons. J. Physiol. (Lond.) 497: 3:761-772, 1996.
33. KIRK, C. J., REDDY, N. L., FISCHER, J. B., WOLCOTT, T. C., KNAPP, A. G. AND MCBURNEY, R. N.: In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites. J. Pharmacol. Exp. Ther. 271: 1080-1085, 1994.
34. LARGENT, B. L., WIKSTROM, H., GUNDLACH, A. L. AND SNYDER, S. H.: Structural determinants of a receptor affinity. Mol. Pharmacol. 32: 772-784, 1988.
35. LEGENDRE, P. AND WESTBROOK, G. L.: Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol. Pharmacol. 40: 289-298, 1991.
36. LOCKHART, B. P., SOULARD, P., BENICOURT, C., PRIVAT, A. AND JUNIEN, J-L.: Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675: 110-120, 1995.
37. MACDONALD, J. F., BARTLETT, M. C., MODY, I., PAPHAPILL, P., REYNOLDS, J. N., SLATER, M. W., SCHNEIDERMAN, J. H. AND PENNEFATHER, P. S.: Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J. Physiol. (Lond.) 432: 483-508, 1991.
38. MACDONALD, J. W. AND JOHNSTON, M. V.: Pharmacology of NMDA-induced brain injury in an in vivo perinatal rat model. Synapse 6: 179-188, 1990.
39. MARTIN, W. R., EADES, C. E., THOMPSON, J. A., HUPPLER, R. E. AND GILBERT, P. E.: The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197: 517-532, 1976.
40. MATSUMOTO, R. R., HEMSTREET, M. K., LAI, N. L., THURKAUF, A., DE COSTA, B. R., RICE, K. C., HELLEWELL, S. B., BOWEN, W. D. AND WALKER, J. M.: Drug specificity of pharmacological dystonia. Pharmacol. Biochem. and Behav. 36: 151-155, 1990.
41. 125I-Ifenprodil: Synthesis and characterization of binding to a polyamine-sensitive site in cerebral cortical membranes. J. Neurochem. 61: 120-126, 1993.
42. MONNET, F. P., DEBONNEL, G., JUNIEN, J. L. AND DE MONTIGNY, C.: N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur. J. Pharmacol. 179: 441-445, 1990.
43. MONNET, F. P., DEBONNEL, G. AND DE MONTIGNY, C.: In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 261: 123-130, 1992.
44. 3H]-noradrenaline release in rat hippocampal slices. Br. J. Pharmacol. 119: 65-72, 1996.
45. MONYER, H., SPRENGEL, R., SCHOEPFER, R., HERB, A., HIGUCHI, M., LOMELI, H., BURNASHEV, N., SAKMANN, B. AND SEEBURG, P. H.: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (Wash. D.C.) 256: 1217-1221, 1992.
46. MORIYOSHI, K., MASU, M., ISHII, T., SHIGEMOTO, R., MIZUNO, N. AND NAKANISHI, S.: Molecular cloning and characterization of the rat NMDA receptor. Nature (Lond.) 354: 31-37, 1991.
47. QUIRION, R., BOWEN, W. D., ITZHAK, Y., JUNIEN, J. L., MUSACCHIO, J. M., ROTHMAN, R. B., SU, T-P., TAM, S. W. AND TAYLOR, D. P.: A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13: 85-86, 1992.
48. 3H]-l,3-di(2-toloyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by σ ligands. Mol. Pharmacol. 39: 222-232, 1991.
49. SNYDER, S. H. AND LARGENT, B. L.: Receptor mechanisms in antipsychotic drug action: Focus on sigma receptors. J. Neuropsychiatry 1: 7-15, 1989.
50. 3H]-SKF 10,047 to etorphine-inaccessible sites in guinea pig brain. J. Pharmacol. Exp. Ther. 223: 284-290, 1982.
51. SUGIHARA, H., MORIYOSHI, K., ISHII, T., MASU, M. AND NAKANISHI, S.: Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185: 826-832, 1992.
52. TAKAHASHI, H., KIRSCH, J. R., HASHIMOTO, K., LONDON, E. D., KOEHLER, R. C. AND TRAYSTMAN, R. J.: PPBP [4-phenyl-1-(4-phenylbuty])piperidine, a potent σ-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke 26: 1676-1682, 1995.
53. TAKAHASHI, H., KIRSCH, J. R., HASHIMOTO, K., LONDON, E. D., KOEHLER, R. C. AND TRAYSTMAN, R. J.: PPBP [4-phenyl-1-(4-phenylbuty])piperidine decreases brain injury after transient focal ischemia in rats. Stroke 27: 2120-2123, 1996.
54. 3H]-haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. U.S.A. 81: 5618-5621, 1984.
55. TAM, S. W. AND ZHANG, A-Z.: σ and PCP receptors in human frontal cortex membranes. Eur. J. Pharmacol. 154: 343-344, 1988.
56. TAYLOR, D. P. AND DEKLEVA, J.: Potential antipsychotic agent BMY 14802 selectively binds to σ sites. Drug Dev. Res. 11: 65-70, 1987.
57. WALKER, J. M., BOWEN, W. D., WALKER, F. O., MATSUMOTO, R. R., DE COSTA, B. AND KENNER, K. C.: Sigma receptors: Biology and function. Pharmacol. Rev. 42: 355-402, 1990.
58. WHITTEMORE, E. R., LOO, D. T., WATT, J. A. AND COTMAN, C. W.: A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67: 921-932, 1995.
59. 18F-labeled guanidines. J. Med. Chem. 34: 1867-1870, 1991.
60. WILLIAMS, K.: Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44: 851-859, 1993.
61. WOODWARD, R. M., HUETTNER, J. E., GUASTELLA, J., KEANA, J. F. W. AND WEBER, E.: In vitro pharmacology of ACEA-1021 and ACEA-1031: Systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47: 568-581, 1995.
62. WU, X-Z., BELL, J. A., SPIVAK, C. E., LONDON, E. D. AND SU, T-P.: Electrophysiological and binding studies on intact NCB-20 cells suggest presence of low affinity sigma receptor. J. Pharmacol. Exp. Ther. 257: 351-358, 1991.
63. YAMAMOTO, H., YAMAMOTO, Y., SAGI, N., KLENEROVA, V., GOJI, K., KAWAI, N., BABA, A., TAKAMORI, E. AND MOROJI, T.: Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ1 site. J. Neurosci. 15: 731-736, 1995.
64. ZHONG, J., RUSSEL, S. L., PRICHETT, D. B., MOLINOFF, P. B. AND WILLIAMS, K: Expression of messenger RNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 45: 846-853, 1994.
65. ZUKIN, S. R., BRADY, K. T., SILFER, B. L. AND BALSTER, R. L.: Behavioral and biochemical steroselectivity of sigma opiate/PCP receptors. Brain Res. 294: 174-177, 1984.